ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 0.31 and traded as low as GBX 0.18. ValiRx shares last traded at GBX 0.19, with a volume of 54,767,023 shares traded.
ValiRx Stock Performance
The company has a current ratio of 9.66, a quick ratio of 1.27 and a debt-to-equity ratio of 0.19. The business’s 50 day moving average is GBX 0.23 and its two-hundred day moving average is GBX 0.30. The company has a market cap of £1.40 million, a PE ratio of -0.20 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
